Global X Russell 2000 ETF
RSSL - ETF AI Analysis
Top Page
Global X Russell 2000 ETF (RSSL)
RSSL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.41B
- Region
- North America
- Expense Ratio
- 0.08%
- Beta
- 1.00
- Issuer
- Global X
- Inception Date
- Jun 05, 2024
- Dividend Yield
- 1.35%
- Asset Class
- Equity
- Index Tracked
- Russell 2000 RIC Capped Index - Benchmark TR Gross
RSSL Summary
The Global X Russell 2000 ETF (RSSL) is a fund that follows the Russell 2000 Index, which focuses on smaller U.S. companies. These are businesses that are past the start-up stage but still growing, across many areas like health care, technology, finance, and industrials. Examples of companies it holds include JFrog and SM Energy. Someone might invest in RSSL to tap into the growth potential of small companies while spreading their money across hundreds of stocks for diversification. A key risk is that small-cap stocks can be more volatile, so the ETF’s value can move up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.08%, which means you’ll pay about $0.80 per year for every $1,000 invested. That’s lower than the average ETF because it’s a passively managed fund that simply tracks the Russell 2000 small-cap index instead of paying managers to pick individual stocks.
What would affect this ETF?
RSSL could benefit if the U.S. economy grows steadily, as small-cap companies in sectors like health care, technology, and financials often see faster expansion and innovation in good business conditions. On the downside, higher interest rates, economic slowdowns in the U.S., or tighter regulations on health care and financial firms could hurt these smaller, more sensitive companies and make the ETF more volatile.
RSSL Top 10 Holdings
RSSL is a small-cap U.S. fund where a handful of fast-moving names set the tone. Health care and biotech are in the driver’s seat: Glaukos is rising on strong sales, while Twist Bioscience and 10x Genomics show powerful longer-term momentum but more mixed, recently lagging action. Tech exposure via JFrog adds another bright spot, with the stock steadily climbing. On the flip side, industrial player Moog has been losing steam, modestly holding back returns. Overall, the ETF leans into innovative U.S. small caps, with health care and tech doing most of the heavy lifting.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Glaukos | 0.47% | $6.83M | $14.55B | 167.64% | 61Neutral | |
| BrightSpring Health Services, Inc. | 0.40% | $5.85M | $14.17B | 124.28% | 67Neutral | |
| JFrog | 0.40% | $5.73M | $14.16B | 90.67% | 73Outperform | |
| Moog | 0.33% | $4.78M | $10.76B | 69.21% | 73Outperform | |
| UMB Financial | 0.33% | $4.77M | $10.17B | 22.77% | 77Outperform | |
| ViaSat | 0.32% | $4.64M | $9.43B | 89.27% | 56Neutral | |
| TG Therapeutics | 0.32% | $4.59M | $9.75B | 108.37% | 65Neutral | |
| Vaxcyte | 0.31% | $4.56M | $10.03B | 39.12% | 50Neutral | |
| Ryman | 0.31% | $4.52M | $9.32B | 43.99% | 66Neutral | |
| CareTrust REIT | 0.31% | $4.45M | $9.81B | 6.52% | 80Outperform |
RSSL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RSSL, the sentiment is Negative. The current price of 108.71 is below the 20-day moving average (MA) of 108.88, below the 50-day MA of 109.80, and below the 200-day MA of 108.90, indicating a bearish trend. The MACD of -0.11 indicates Negative momentum. The RSI at 48.29 is Neutral, neither overbought nor oversold. The STOCH value of 65.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RSSL.
RSSL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $108.71 | $116.00(6.71% Upside) | $1.41B | 0.08% | 63Neutral | |
| $36.21 | $42.97(18.67% Upside) | $8.94B | 0.25% | 67Neutral | |
| $45.25 | $59.29(31.03% Upside) | $6.86B | 0.28% | 63Neutral | |
| $85.34 | $106.49(24.78% Upside) | $4.26B | 0.15% | 66Neutral | |
| $130.88 | $164.12(25.40% Upside) | $4.16B | 0.07% | 66Neutral | |
| $58.04 | $65.81(13.39% Upside) | $3.87B | 0.59% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RSSL | Global X Russell 2000 ETF | 108.71 | 18.64 | 20.70% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 36.21 | 6.88 | 23.47% | |
| FESM | Fidelity Enhanced Small Cap ETF | 45.25 | 10.05 | 28.55% | |
| SMLF | iShares MSCI USA Small-Cap Multifactor ETF | 85.34 | 14.88 | 21.11% | |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 130.88 | 25.90 | 24.67% | |
| CALF | Pacer US Small Cap Cash Cows 100 ETF | 58.04 | 15.90 | 37.72% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
